Speeches and presentations

14 Dec 2006
GlaxoSmithKline Hosts Investor Roundtable Meeting in New York
Chris Viehbacher, President, US Pharmaceuticals, hosted a Roundtable Meeting on 14 December in New York. David Pernock, SVP, General Pharmaceuticals Business Unit, Stan Hull, SVP, US Pharmaceuticals and Steve Stefano, SVP, Managed Care and Neurohealth gave presentations on the US pharmaceutical business. The meeting was attended by approximately 100 institutional investors and portfolio managers. Slides from the presentations are available for view.

Please note these downloads are large pdf documents.

04 Dec 2006
GSK Avandia in Focus meeting
David Stout, President, Pharmaceutical Operations, together with senior representatives from R&D and US Pharmaceutical Operations gave a presentation on GSK’s Avandia portfolio, followed by a Q&A session.

09 Nov 2006
Credit Suisse 6th Annual European Large Cap Pharmaceutical Conference
Mr Andrew Witty, President, Pharmaceuticals Europe gave a presentation at the Credit Suisse 6th Annual European Large Cap Pharmaceutical Conference on 9 November in London.

08 Nov 2006
Cowen and Company Global Health Care Conference
Mr Julian Heslop, Chief Financial Officer gave a presentation at the Cowen and Company Global Health Care Conference on 8 November in London.

26 Oct 2006
GlaxoSmithKline 2006 Q3 Results

21 Sep 2006
Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Dr Jean Stéphenne, President GSK Biologicals gave a presentation at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference on 21 September in London. He presented to a large number of investors, around 100, consisting of portfolio and fund managers. Jean spoke on delivering GSK's promising and unique vaccine pipeline.

26 Jul 2006
GlaxoSmithKline 2006 Q2 Results

13 Jun 2006
ABN AMRO Global Vaccines Conference
Dr Thomas Breuer, Vice President, Worldwide Regulatory, Epidemiology & Safety, gave a presentation at the ABN AMRO Global Vaccines Conference on 13 June in London. He presented to a small number of investors, around 40, consisting of portfolio and fund managers. Thomas spoke on delivering GSK’s promising and unique vaccine pipeline.

13 Jun 2006
Goldman Sachs Twenty-Seventh Annual Global Healthcare Conference
JP Garnier, Chief Executive Officer, was the featured lunchtime speaker at the Goldman Sachs Twenty-Seventh Annual Global Healthcare Conference on 13 June in California. More than 400 institutional investors and portfolio managers attended the conference. JP’s presentation focused on R&D productivity within the pharmaceutical industry.

7 Jun 2006
GlaxoSmithKline Hosts Investor Roundtable Meeting in Philadelphia
GlaxoSmithKline hosted an investor roundtable meeting on 7 June at its Philadelphia offices. Senior members of the US commercial operations management team and R&D oncology medicine development center gave presentations and lead Q&A discussions on their respective areas of operation. Slides from the presentations are available for view.

Please note these downloads are large pdf documents.

04 Jun 2006
GlaxoSmithKline Investor Luncheon on Cervarix and Cancer Immunotherapy at ASCO
Dr Philippe Monteyne, Vice President Global Vaccine Development and Dr Vincent Brichard, Director, Worldwide Clinical development Cancer Program gave presentations on 4 June at an investor luncheon meeting hosted by GSK in Atlanta, Georgia. Dr Monteyne reviewed Cervarix data and Dr Brichard reviewed GSK’s cancer immunotherapy MAGE-A3 vaccine.  Data for these products was presented at the ASCO meeting. A question and answer session followed their presentations.

03 Jun 2006
GlaxoSmithKline Investor Luncheon on Tykerb at ASCO
Dr Paolo Paoletti, Senior Vice President MDC for Oncology gave a presentation on 3 June at an investor luncheon meeting hosted by GSK in Atlanta, Georgia. Dr Paoletti reviewed Tykerb data that was presented at the ASCO meeting. A question and answer session followed his presentation.

02 May 2006
Deutsche Bank Securities 31st Annual Healthcare Conference
David Stout, President, Pharmaceutical Operations, gave a presentation at the Deutsche Bank Securities 31st Annual Healthcare Conference on 2 May in Boston. The presentation was attended by over 100 institutional investors and portfolio managers. David's presentation consisted of ten minutes of opening remarks on the first quarter results and pipeline progress followed by 30 minutes of Q&A.

27 Apr 2006
GlaxoSmithKline 2006 Q1 Results

01 Mar 2006
Citigroup Healthcare Conference
JP Garnier, Chief executive officer, gave a presentation at the Citigroup Health Care Conference on 1 March in Washington, DC. The presentation was attended by over 100 institutional investors and portfolio managers. JP discussed some of the strong fundamentals supporting the pharmaceutical sector and provided an overview of GSK's growth drivers and pipeline.

09 Feb 2006
Merrill Lynch Global Pharmaceutical, Biotechnology and Global Device Conference
Steve Stefano, Senior vice president of Managed markets & neurohealth divisions gave a presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology and Global Device Conference in New York City on 9 February. More than 100 institutional investors and portfolio managers attended the conference.

8 Feb 2006
GlaxoSmithKline 2005 Annual Results

09 Jan 2006
JPMorgan 24th Annual Healthcare Conference
Steve Stefano, Senior vice president of Managed markets & neurohealth divisions gave a presentation at the JP Morgan 24th Annual Healthcare Conference in San Francisco on 9 January.